Class Examples named by WADA Status GHRH analogs CJC-1293, CJC-1295, sermorelin, tesamorelin S2 prohibited at all times GH secretagogues and mimetics Anamorelin, capromorelin, ibutamoren (MK-677), ipamorelin, lenomorelin (ghrelin), macimorelin, tabimorelin S2 prohibited at all times GH-releasing peptides (GHRPs) Alexamorelin, examorelin (hexarelin), GHRP-1, GHRP-2 (pralmorelin), GHRP-3, GHRP-4, GHRP-6 S2 prohibited at all times Erythropoietin and EPO-receptor agonists Erythropoietins and agents affecting erythropoiesis S2 prohibited at all times Growth hormone and growth factors Growth hormone, IGF-1 and its analogs, and related growth factors affecting muscle, tendon or ligament S2 prohibited at all times Unapproved experimental peptides BPC-157 and similar compounds with no regulatory approval S0 prohibited at all times The S0 point is the one most often missed
When fasting, this function becomes even more important, as the body relies more heavily on fat for fuel
Ongoing clinical trials evoke and assess oral semaglutides clinical effectiveness and disease-modifying impacts in early-stage Alzheimers disease (AD) (Cummings et al., 2025)
Han, J.-H
Toxin Rev 39:115122 McGill MR (2016) The past and present of serum aminotransferases and the future of liver injury biomarkers
Beck specifically formulates our Lipo-B12 injections to help burn stubborn fat more efficiently than diet and exercise alone